Skip to main content
 

Main menu

  • About Us
  • The Data
  • The Analysis
  • Research Examples
  • In The Press
  • Contact Us

In The Press

Analyze This: Viewing Pharma Markets from Wall Street’s Perspective

October 25, 2011

Click here to learn more.

  • Request a Free Trial

In The Press

  • Report Finds Managed Care Pushing Back at Lipitor
  • inThought Report Says New Wave of Cardiology Drugs to be Big Boon
  • inThought On Hep C Market and Incivek Launch
More

Research Examples

RESEARCH ALERT:

  • ASHG Preview - 10/14/2010
  • Cardiovascular Device Update - 05/06/2011
  • Could Cholesterol Increases be Good for Actemra and Tofacitinib? - 09/15/2011
  • GlaxoSmithKline’s One-Two Punch against Melanoma - 9/20/2011
  • Incivek: Biggest Drug Launch in History. Is it Sustainable? - 11/02/2011
  • Innovative Medicine Shaping the Cardiology Market - 12/20/2011
  • New Kinase Inhibitors Target NSCLC - 11/04/2010
  • New Targets & Strategies in Focus at AACR - 04/12/2011
  • No Joy for Obesity Drug Developers - 08/10/2011
  • Safety Issues May Hit Gilenya - 08/25/2011
  • The Exciting Potential of OrthoBiologics - 05/09/2011
  • Vertex: More than Incivek - 11/28/2011

Secondary menu

  • Home
  • About Us
  • The Data
  • The Analysis
  • Research Examples
  • Request a Free Trial
  • Contact Us
Visit Wolters Kluwer Pharma Solutions
©2012 Wolters Kluwer Pharma Solutions